Usefulness of genetic susceptibility and biomarkers for evaluation of environmental health risk

Environmental and Molecular Mutagenesis

Volumn 37, Issue 3, 2001, Pages 215-225

  Au, William W ^a   Oh, Hye Young ^b   Grady, James ^a,c   Salama, Salama A ^d   Heo, Moon Young ^e  

^a University of Texas Medical Branch School of Medicine   (United States)

^b Korea Food and Drug Administration   (South Korea)

^c Al Azhar University   (Egypt)

^d Kangwon National University   (South Korea)

^e Community Health ^*  (United States)

Author keywords

Biomarkers; Biostatistics; Chromosome aberrations; Cigarette smoking; Experimental design; Genetic susceptibility; Lung cancer; Polymorphic metabolizing genes

Indexed keywords

BIOLOGICAL MARKER; CYTOCHROME P450 1A1; CYTOCHROME P450 2E1; GLUTATHIONE TRANSFERASE;

ARTICLE; BIOSTATISTICS; CANCER SUSCEPTIBILITY; CIGARETTE SMOKING; ENVIRONMENTAL FACTOR; ENZYME POLYMORPHISM; ETHNIC DIFFERENCE; GENE EXPRESSION REGULATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; LUNG CANCER; PREDICTION; XENOBIOTIC METABOLISM;

ACETYLTRANSFERASES; ARYLAMINE N-ACETYLTRANSFERASE; ARYLDIALKYLPHOSPHATASE; BIOLOGICAL MARKERS; ENVIRONMENT; ESTERASES; EVALUATION STUDIES; FORECASTING; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HEALTH STATUS INDICATORS; HUMANS; ISOENZYMES; LUNG NEOPLASMS; POLYMORPHISM, GENETIC; SAMPLE SIZE; VARIATION (GENETICS);

EID: 0035003557     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/em.1030     Document Type: Article

References (113)

1. Association of the NAT 1* 10 genotype with increased chromosome aberrations and higher lung cancer risk in cigarette smokers
2. Future research directions for valuating human genetic and cancer risk from environmental exposures
3. Glutathione dependent bioactivation of haloalkanes
4. Strategies for conducting human population monitoring studies
5. Genetic polymorphisms in human xenobiotica metabolizing enzymes as susceptibility factors in toxic response
6. Human glutathione S-transferases
7. The role of individual susceptibility in cancer burden related to environmental exposure
8. Impact of adduct determination on the assessment of cancer susceptibility
9. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers
10. Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer
11. Modulation of DNA adduct levels in human mononuclear white blood cells and granulocytes by CYP1A1 CYP2D6 and GSTM1 genetic polymorphisms
12. Analysis of human urine for pyridine-N-oxide metabolites of 4-(methyl nitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific lung carcinogen
13. A C4887A polymorphism in exon 7 of human CYP1A1: Population frequency, mutation linkages and impact on lung cancer susceptibility
14. Glutathione S-transferase mu genotype, diet, and smoking as determinants of sister chromatid exchange frequency in lymphocytes
15. Smoking and the molecular epidemiology of lung cancer
16. New goals for the U.S. human genome project, 1998-2003
17. Predisposing genes and increased chromosome aberrations in lung cancer cigarette smokers
18. Racial differences in restriction fragment length polymorphisms and messenger RNA inducibility of human CYP1A1 gene
19. Functional significance of different human CYP1A1 genotypes
20. Recent advances in understanding the molecular basis of polymorphisms in genes encoding cytochrome P450 enzymes
21. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin
22. Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: Studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers
23. Genetic metabolic polymorphisms and the risk of cancer: A review of the literature
24. Polymorphism of metabolizing genes and lung cancer histology: Prevelance of CYP2E1 in adenocarcinoma
25. Combined genetic polymorphism and risk for development of lung cancer
26. Interactions between genetic predisposition and environmental toxicants for development of lung cancer
27. A case-control study of cytochrome P450 1A1, glutathione S-transferase M1, cigarette smoking and lung cancer susceptibility
28. Glutathione transferase activity and formation of macromolecular adducts in two cases of acute methyl bromide poisoning
29. Polycyclic aromatic hydrocarbon-DNA adducts in smokers and their relationship to micronutrient levels and the glutathione-S-transferase M1 genotype
30. Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects
31. Elucidation of catalytic specificities of human cytochrome P450 and glutathione S-transferease enzymes and relevance to molecular epidemiology
32. Frequency of glutathione S-transferase M1 deletion in smokers with emphysema and lung cancer
33. Gene-environment interactions in human lung cancer
34. Genetic polymorphisms in the 5′-flanking region change transcriptional regulation of the human cytochrome P450 IIE1 gene
35. The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung
36. Polymorphism of the CYP1A1 and glutathione-S-transferase gene in Korean lung cancer patients
37. The molecular basis of the human serum paraoxonase activity polymorphism
38. Aromatic DNA adducts, micronuclei and genetic polymorphism for CYP1A1 and GST1 in chimney sweeps
39. Acetylator phenotype in colorectal carcinoma
40. Susceptibility to lung cancer in light smokers associated with CY1A1 polymorphisms in Mexican- and African-Americans
41. Recombinant rat and hamster N-acetyltransferase-1 and -2: Relative rates of N-acetylation or arylamines and N,O-acyltransfer with arylhydroxamic acids
42. Effects of glutathione S-transferases GSTM1 and GSTT1 genotypes on lung cancer risk in smokers
43. Polymorphisms for aromatic amine metabolism in humans: Relevance for human carcinogenesis
44. Cytochrome P450IIEI genetic polymorphism, racial variation, and lung cancer risk
45. Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo
46. The CYP1A1 gene and cancer susceptibility
47. A race-specific genetic polymorphism in the CYP1A1 gene is not associated with lung cancer in African Americans
48. Polymorphisms in the glutathione S-transferase class mu and theta genes interact and increase susceptibility to lung cancer in minority populations (Texas, United States)
49. Lung cancer risk of GSTM1 null genotype is dependent on the extent of tobacco smoke exposure
50. Risk of smoking for squamous and small cell carcinomas of the lung modulated by combinations of CYP1A1 and GSTM1 gene polymorphisms in a Japanese population
51. Landscaping the cancer terrain
52. Cytochrome P450 CYP2D6 gene polymorphism and lung cancer susceptibility in Caucasians
53. Genetic instability and the mutator phenotype. Studies in ulcerative colitis
54. Polymorphism of glutathione S-transferase M1 and lung cancer risk among African-Americans and Caucasians in Los Angeles County, California
55. Genetic polymorphism of CYP2D6 and lung cancer risk in African-Americans and Caucasians in Los Angeles County
56. Organophosphate poisoning
57. Glutathione conjugate mediated toxicities
58. Contribution of genetic and nutritional factors to DNA damage in heavy smokers
59. Glutathione S-transferase mu polymorphism and susceptibility to lung cancer in the Portuguese population
60. Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta
61. Cytogenetic Markers of Susceptibility: Influence of polymorphic carcinogen-metabolizing enzymes
62. Glutathione S-transferase mu1 and N-acetyltransferase 2 genetic polymorphisms and exposure to tobacco smoke in nonsmoking and smoking lung cancer patients and population controls
63. Mammalian epoxide hydrases inducible enzymes catalysing the inactivation of carcinogenic and cytotoxic metabolites derived from aromatic and olefinic compounds
64. Opportunity for initiation of an environmental health programs in Korea
65. Association between a crytochrome P450 CYP1A1 genotype and incidence of lung cancer
66. Cytochrome P450 2E1 polymorphism as a risk factor for lung cancer: In relation to p53 gene mutation
67. 7-guanyl)ethyl]glutathione adduct in glutathione-mediated binding of 1,2-dibromoethane to DNA
68. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of genetic polymorphism
69. Genetic polymorphism of cytochrome P450 IIE1 in a Swedish population. Relation to incidence of lung cancer
70. Genetic polymorphism of xenobiotic metabolizing enzymes among Chinese lung cancer patients
71. Genetic polymorphism and interethnic variability of plasma paroxonase activity
72. The mutagenic effect of 1,2-dichloroethane on Salmonella typhimurium. I. Activation through conjugation with glutathione in vitro
73. Diagnosis of polymorphism in carcinogen-activating and inactivating enzymes and cancer susceptibility: A review
74. Molecular epidemiology of the humna glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility
75. Differences in the urinary metabolites of tobacco-specific lung carcinogen
76. Combined effect of polymorphic GST genes on individual susceptibility to lung cancer
77. Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers
78. Influence of GSTM1 and GSTT1 polymorphisms on the frequency of chromosome aberrations in lymphocytes of smokers and pesticide-exposed greenhouse workers
79. Smoking-associated bulky DNA adducts in bronchial tissue related to CYP1A1 MspI and GSTM1 genotypes in lung patients
80. Glutathione-S-transferase (GST) theta polymorphism influences background SCE rate
81. The role of human glutathione transferases and epoxide hydrolases in the metabolism of xenobiotics
82. Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion
83. Genetic polymorphism of CYP2D6 and lung cancer risk
84. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans
85. Pharmacogenetics: Detecting sensitive populations
86. Characterization of human lung microsomal cytochrome P450 1A1 and its role in oxidation of chemical carcinogens
87. Effect of glutathione S-transferase M1 polymorphisms on biomarkers of exposure and effects
88. Gene deficiency of glutathione S-transferase isoform associated with susceptibility to lung cancer in a Chinese population
89. Lung cancer risk and CYP1A1 genotype in African Americans
90. Drug metabolism polymorphism as modulators of cancer susceptibility
91. Enhancement of bacterial mutagenicity of bifunctional alkylating agents by expression of mammalian glutathione S-transferase
92. Human glutathione S-transferase T1-enhances mutagenicity of 1,2-dibromomethane, dibromomethane and 1,2,3,4-deepoxybuthane in Salmonella tyhimurium
93. Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) polymorphisms and lung cancer risk among Northwestern Mediterraneans
94. Influence of GSTM1 and NAT2 genotypes on placemental DNA adducts in an environmentally exposed population
95. Formation of reactive intermediates by phase II enzymes: Glutathione-dependent bioactivation reactions
96. Markers for cytogenetic damage in smokers: Associations with plasma anti-oxidants and glutathione S-transferase mu
97. "A" esterases and their role in regulating the toxicity of organophosphates
98. Effects of genetic polymorphism of metabolic enzymes, nutrition, and lifestyle factors on DNA adduct formation in lymphocytes
99. Gene deletion of glutathione S-transferase theta: Correlation with induced genetic damage and potential role in endogenous mutagenesis
100. Needle-in-a-haystack detection and identification of base substitution mutations in human tissues
101. Oncogenic base substitution mutations in circulating leukocytes of normal individuals
102. Effects on sister chromatid exchange frequency of aldehyde dehydrogenase 2 genotype and smoking in vinyl chloride workers
103. Associations between cytochrome P4502E1 genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancer
104. Cytochrome P450 CYP1A1 MspI polymorphism and lung cancer susceptibility